Related Experiment Video
Updated: Jun 16, 2026
07:15
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Congenital short QT syndrome
Lia Crotti1, Erika Taravelli, Giulia Girardengo
1Section of Cardiology, Department of Lung, Blood and Heart, University of Pavia, Pavia, Italy. l.crotti@smatteo.pv.it
Indian Pacing and Electrophysiology Journal
|February 4, 2010
Summary
Short QT Syndrome (SQT) is a genetic disorder causing dangerous heart arrhythmias due to short repolarization. Gain-of-function mutations in K+ channel genes are identified, with ICD implantation and quinidine as potential treatments.
Area of Science:
- Cardiology
- Genetics
- Electrophysiology
Background:
- Short QT Syndrome (SQT) is a rare genetic disorder.
- Characterized by a short QT interval, leading to atrial fibrillation and life-threatening ventricular arrhythmias.
- Often presents with a family history of sudden cardiac death.
Purpose of the Study:
- To describe the genetic basis and clinical characteristics of Short QT Syndrome.
- To review current diagnostic and therapeutic strategies.
- To highlight ongoing research into pharmacological treatments.
Main Methods:
- Electrophysiological studies to assess atrial and ventricular refractory periods.
- Genetic analysis to identify mutations in K+ channel genes (KCNH2, KCNQ1, KCNJ2).
- Review of clinical data and treatment outcomes.
Main Results:
- Identified gain-of-function mutations in KCNH2 (SQT1), KCNQ1 (SQT2), and KCNJ2 (SQT3) genes.
- Electrophysiology shows short refractory periods and inducible arrhythmias.
- Implantable cardioverter-defibrillator (ICD) implantation is a current therapeutic strategy, with concerns for pediatric patients.
Conclusions:
- SQT is caused by genetic defects in cardiac K+ channels, leading to abbreviated repolarization.
- Current management involves ICDs, but pharmacological options like quinidine are under investigation.
- Further clinical data is needed to confirm the efficacy and safety of treatments.
Related Concept Videos
01:18Dysrhythmias IV: Characteristics of Bradyarrhythmias
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
01:29Dysrhythmias III: Characteristics of Dysrhythmias
Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
01:20Inborn Errors of Metabolism
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
01:15Dysrhythmias I: Introduction
Dysrhythmias refers to abnormalities in the heart's rhythm. They result from disruptions in the heart's electrical conduction system, which includes the sinoatrial(SA)node, atrioventricular(AV) node, the bundle of His, bundle branches, and Purkinje fibers.Definition and PathophysiologyDysrhythmias result from disorders of impulse formation, impulse conduction, or both. The heart contains specialized cells in the sinoatrial node, atrioventricular node, and the bundle of His and Purkinje fibers...